Introduction Subacute sclerosing panencephalitis (SSPE) is a late, rare and usually fatal complication of measles infection. Although a very high incidence of SSPE in Papua New Guinea (PNG) was first recognized 20 years ago, estimated measles vaccine coverage has remained at ≤70% since and a large measles epidemic occurred in 2002. We report a series of 22 SSPE cases presenting between November 2007 and July 2009 in Madang Province, PNG, including localized clusters with the highest ever reported annual incidence. Methodology/Principal Findings As part of a prospective observational study of severe childhood illness at Modilon Hospital, the provincial referral center, children presenting with evidence of meningo-encephalitis were assessed in detail including lumbar puncture in most cases. A diagnosis of SSPE was based on clinical features and presence of measles-specific IgG in cerebrospinal fluid and/or plasma. The estimated annual SSPE incidence in Madang province was 54/million population aged <20 years, but four sub-districts had an incidence >100/million/year. The distribution of year of birth of the 22 children with SSPE closely matched the reported annual measles incidence in PNG, including a peak in 2002. Conclusions/Significance SSPE follows measles infections in very young PNG children. Because PNG children have known low seroconversion rates to the first measles vaccine given at 6 months of age, efforts such as supplementary measles immunisation programs should continue in order to reduce the pool of non-immune people surrounding the youngest and most vulnerable members of PNG communities.
References
[1]
Duke T, Mgone CS (2003) Measles: not just another viral exanthem. Lancet 361: 763–773. doi: 10.1016/S0140-6736(03)12661-X
[2]
Dabbagh A, Gacic-Dobo M, Simons E, Featherstone D, Strebel P, et al. (2009) Global measles mortality, 2000–2008. MMWR Morb Mortal Wkly Rep 58: 1321–1326.
[3]
Warrell D, Farrar J (2003) Viral Infections of the Central Nervous System. In: Warrell D, Cox T, Firth J, Benz E, editors. Oxford textbook of medicine. 4th ed. Oxford: Oxford University Press. pp. 1138–1139.
[4]
Mgone CS, Mgone JM, Takasu T, Miki K, Kawanishi R, et al. (2003) Clinical presentation of subacute sclerosing panencephalitis in Papua New Guinea. Trop Med Int Health 8: 219–227. doi: 10.1046/j.1365-3156.2003.01020.x
[5]
Sanders RC, Brian M, Rongap A, Watt PD, Alpers MP (1990) High incidence of subacute sclerosing panencephalitis (SSPE) in young children in Papua New Guinea. Med J Aust 153: 740. doi: 10.1017/s0950268800050044
[6]
Takasu T, Mgone JM, Mgone CS, Miki K, Komase K, et al. (2003) A continuing high incidence of subacute sclerosing panencephalitis (SSPE) in the Eastern Highlands of Papua New Guinea. Epidemiol Infect 131: 887–898. doi: 10.1017/S0950268803008999
[7]
Paediatrics Society of PNG (2005) Standard treatment for common illnesses of children in PNG. 8th edition. Port Moresby.
[8]
National Statistical Office of Papua New Guinea (2002) Papua New Guinea 2000 census. Port Moresby: Government of Papua New Guinea.
[9]
Duke T (2003) The crisis of measles and the need to expand the ways of delivering vaccines in Papua New Guinea. P N G Med J 46: 1–7.
[10]
Senn N, Riddell M, Omena M, Siba P, Reeder J, et al. (2010) Measles in Papua New Guinea: An age-specific serological survey. Vaccine 28: 1819–1823. doi: 10.1016/j.vaccine.2009.12.002
[11]
World Health Organization (2009) WHO/UNICEF Review of National Immunization Coverage 1980–2008: Papua New Guinea. Available at: http://www.who.int/immunization_monitori？ng/data/png.pdf. Accessed August 1, 2010.
[12]
World Health Organization (2009) Immunization surveillance, assessment and monitoring: Papua New Guinea reported cases. Available at: http://apps.who.int/immunization_monitor？ing/en/globalsummary/timeseries/tsincide？ncebycountry.cfm?C=PNG. Accessed August 1, 2010.
[13]
World Health Organization Western Pacific Region (2008) Expanded programme on immunization. National Immunization Data - EPI Summaries by Country. Available at: http://www.wpro.who.int/NR/rdonlyres/9DE？B2F01-F04F-4F5D-8AA3-93574BC1FF94/0/EPIC？ountryPosterdatafor2008PNG.pdf. Accessed August 1, 2010.
[14]
Barkin RM, Conrad JL (1973) Current status of measles in the United States. J Infect Dis 128: 353–356. doi: 10.1093/infdis/128.3.353
[15]
De Francisco A, Fauveau V, Sarder AM, Chowdhury HR, Chakraborty J, et al. (1994) Measles in rural Bangladesh: issues of validation and age distribution. Int J Epidemiol 23: 393–399. doi: 10.1093/ije/23.2.393
[16]
World Health Organization (2006) The WHO Child Growth Standards. Available at: http://www.who.int/childgrowth/standards？/en. Accessed August 1, 2010.
[17]
Molyneux ME, Taylor TE, Wirima JJ, Borgstein A (1989) Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q J Med 71: 441–459.
[18]
World Health Organization CDC (2000) Severe falciparum malaria. Trans R Soc Trop Med Hyg 94: Suppl 1S1–90.
[19]
Karnovsky DB, Burchenal JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod C, editor. Evaluation of Chemotherapeutic Agents. New York: Columbia University Press. 196 p.
[20]
Laman M, Manning L, Hwaiwhange I, Vince J, Aipit S, et al. (2010) Lumbar puncture in children from an area of malaria endemicity who present with a febrile seizure. Clin Infect Dis 51: 534–540. doi: 10.1086/655679
[21]
Tageo.com (2009) A database of geographic coordinate information. Available at: http://www.tageo.com/index-e-pp-v-12.htm？?Madang. Accessed August 1, 2010.
[22]
Lucas KM, Sanders RC, Rongap A, Rongap T, Pinai S, et al. (1992) Subacute sclerosing panencephalitis (SSPE) in Papua New Guinea: a high incidence in young children. Epidemiol Infect 108: 547–553. doi: 10.1017/S0950268800050044
[23]
Miller C, Andrews N, Rush M, Munro H, Jin L, et al. (2004) The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990–2002. Arch Dis Child 89: 1145–1148. doi: 10.1136/adc.2003.038489
[24]
Beersma MF, Galama JM, Van Druten HA, Renier WO, Lucas CJ, et al. (1992) Subacute sclerosing panencephalitis in The Netherlands—1976–1990. Int J Epidemiol 21: 583–588. doi: 10.1093/ije/21.3.583
[25]
Bass AG (1993) Vaccines in the national immunization programme. P N G Med J 36: 141–157.
[26]
Wirkas T, Toikilik S, Miller N, Morgan C, Clements CJ (2007) A vaccine cold chain freezing study in PNG highlights technology needs for hot climate countries. Vaccine 25: 691–697. doi: 10.1016/j.vaccine.2006.08.028
[27]
Kurubi J, Vince J, Ripa P, Tefuarani N, Riddell M, et al. (2009) Immune response to measles vaccine in 6 month old infants in Papua New Guinea. Trop Med Int Health 14: 167–173. doi: 10.1111/j.1365-3156.2008.02214.x
[28]
Gans H, Arvin A, Galinus J, Logan L, DeHovitz R, et al. (1998) Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. JAMA 280: 527–532. doi: 10.1001/jama.280.6.527
[29]
Maldonado YA, Lawrence EC, DeHovitz R, Hartzell H, Albrecht P (1995) Early loss of passive measles antibody in infants of mothers with vaccine-induced immunity. Pediatrics 96: 447–450.
[30]
Farrington CP (1991) Subacute sclerosing panencephalitis in England and Wales: transient effects and risk estimates. Stat Med 10: 1733–1744. doi: 10.1002/sim.4780101111
[31]
Mgone JM, Mgone CS, Duke T, Frank D, Yeka W (2000) Control measures and the outcome of the measles epidemic of 1999 in the Eastern Highlands Province. P N G Med J 43: 91–97.
[32]
Griffin DE (2009) Emergence and re-emergence of viral diseases of the central nervous system. Prog Neurobiol.
[33]
Saha V, John TJ, Mukundan P, Gnanamuthu C, Prabhakar S, et al. (1990) High incidence of subacute sclerosing panencephalitis in south India. Epidemiol Infect 104: 151–156. doi: 10.1017/S0950268800054637
Cianchetti C, Cao A, Mastropaolo C, Corda R (1979) Subacute sclerosing panencephalitis in Sardinia. Lancet 1: 829. doi: 10.1016/S0140-6736(79)91351-5
[36]
Soffer D, Rannon L, Alter M, Kahana E, Feldman S (1975) Subacute sclerosing panencephalitis: incidence among ethic groups in Israel. Isr J Med Sci 11: 1–4.
[37]
Michalowicz R, Ignatowicz R, Kostrzewska M (1983) [Familial occurrence of subacute sclerosing panencephalitis (SSPE) in children]. Neurol Neurochir Pol 17: 651–654.
Pipo-Deveza JR, Kusuhara K, Silao CL, Lukban MB, Salonga AM, et al. (2006) Analysis of MxA, IL-4, and IRF-1 genes in Filipino patients with subacute sclerosing panencephalitis. Neuropediatrics 37: 222–228. doi: 10.1055/s-2006-924724
[46]
Miller C, Farrington CP, Harbert K (1992) The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970–1989. Int J Epidemiol 21: 998–1006. doi: 10.1093/ije/21.5.998
[47]
Yilmaz C, Caksen H, Yilmaz N, Guven AS, Bayram I (2007) Two cases of subacute sclerosing panencephalitis associated with brainstem involvement. J Trop Pediatr 53: 280–283. doi: 10.1093/tropej/fmm020
[48]
Aaby P, Andersen M, Knudsen K (1993) Excess mortality after early exposure to measles. Int J Epidemiol 22: 156–162. doi: 10.1093/ije/22.1.156
